22.11.2018
- Cambrex Corporation, which bills itself as the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), has agreed to acquire Avista...
19.09.2018
- Recently, the pharmaceutical contract development and manufacturing organization (CDMO) industry has been extremely active in M&A, as is the pharma and generics industry itself...
